Sisram Medical Ltd. 1696

International markets outside North America grew 16.7%, while DAXXIFY shipments surpass 30,000 vials in China despite margin pressure.

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period, the Company achieved steady overall growth, propelled by accelerating momentum in its Injectables business

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced that it will report its unaudited consolidated interim results for the six months ended June 30, 2026 on Wednesday, August 19, 2026.

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced the official launch of its Titanium Prime treatment concept in Hong Kong SAR. Integrating two flagship EBD platforms, Alma PrimeX and Soprano Titanium Special Edition, the new concept expands the portfolio of combined aesthetic solutions available locally and accelerates Sisram's strategic pivot toward an integrate

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today unveiled 黑金牛奶光 (Black Gold Photofacial) in Mainland China. The next-generation EBD platform combines advanced technology with sustained skin rejuvenation, broadening Sisram's clinical offerings while underscoring its commitment to localized R&D, adaptive clinical strategies, and targeted solutions for China's evolving consum

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that its China manufacturing facility in Miyun, Beijing has commenced operations, with the first locally produced EBD, Alma Rejuve, rolling off the production line. The facility underpins the Company's revamped global smart manufacturing network, bringing its proven Israeli production standards to China to drive iter

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has officially rolled out its Soprano Titanium across Thailand. Supported by its on-the-ground local team and well-established sales network, Sisram has successfully expanded its footprint across both EBD and injectable lines, solidifying Thailand as a core strategic hub and unlocking substantial growth opportunities throughout Sout

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced that its Investor Day was successfully held on May 21 at the Shanghai Bund Finance Center (BFC).

Alma, a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth approach.

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that its audited consolidated annual results for the year ended December 31, 2025 (the "Reporting Period"). During the Reporting Period, the Group's clear strategic focus and disciplined execution drove steady revenue and profit growth, supported